Literature DB >> 28237351

Mortality trends among heroin users treated between 1975 and 2013 in Northern Italy: Results of a longitudinal study.

Raimondo Maria Pavarin1, Angelo Fioritti2, Samantha Sanchini3.   

Abstract

BACKGROUND: The aim of this study was to examine heroin mortality trends and changes in causes of death, across time and age, in a cohort of the heroin population of treated.
METHODS: 5899 subjects attending twelve centers for addiction treatment (SERT) in north Italy following problems due to heroin abuse between 1975 and 2013 were recruited.
RESULTS: This study documented elevated mortality among subjects with primary heroin abuse, with an elevated death risk in all the classes of age, declining until 2009 ad increasing starting from 2010. AIDS was the first cause of death, followed by overdose and liver-related diseases. In the course of time mortality for AIDS and for drug-related deaths has declined, whereas liver mortality and all tumors mortality have risen over time, becoming the most common causes of death by the end of the follow up. As compared with the general population, the excess mortality (SMR) observed for all causes in either sex was 13.2, higher in females (SMR=21.5) as compared with males (SMR=12.1). Higher SMRs were found in 25/34 age-group patients, with a progressive decrease in subjects with age >34years.
CONCLUSIONS: In the course of time, among heroin users, mortality and the causes of death have changed; for SERT clients special attention should be paid to the prevention and treatment of liver-related diseases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIDS; Cohort study; Drug related deaths; Heroin; Liver mortality; Mortality

Mesh:

Year:  2017        PMID: 28237351     DOI: 10.1016/j.jsat.2017.02.009

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  1 in total

1.  Would You Be Surprised If This Patient Died This Year? Advance Care Planning in Substance Use Disorders.

Authors:  Michelle J Fleshner; Amy J Kennedy; Peter J Veldkamp; Julie W Childers
Journal:  J Gen Intern Med       Date:  2019-08-05       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.